Literature DB >> 7585604

Allelotype analysis of childhood acute lymphoblastic leukemia.

S Takeuchi1, C R Bartram, M Wada, A Reiter, Y Hatta, T Seriu, E Lee, C W Miller, I Miyoshi, H P Koeffler.   

Abstract

To identify the genetic events that may play an important role in leukemogenesis of childhood ALL, we report for the first time the allelotyping of childhood ALL. Twenty-four cases of childhood ALL were screened for loss of heterozygosity (LOH) using 101 highly polymorphic microsatellite markers, which are distributed among all autosomal chromosomes. For LOH analysis on both chromosomes 9 and 12, 54 childhood ALL samples were examined. The most frequent allelic loss was found on chromosomal arm 9p, where 20 of 50 (40%) informative samples showed LOH. Moreover, nearly 30% of samples that did not have either homozygous deletions or point mutations of the putative tumor suppressor genes CDKN2/INK4A/p16 and INK4B/p15 on chromosomal arm 9p had LOH at D9S171. Loss of chromosomal arm 12p was also frequent (26%). Mutational analysis suggested that the altered gene on 12p is not the cyclin-dependent kinase inhibitor p27/Kip1, which is also on 12p. Several other regions that had LOH included 1p, 4q, 5p, 6q, 7p, 8p, 9q, 10q, 13q, 17p, 17q, 18q, 19q, and 22q. Of 24 patients, 19 (79%) showed allelic loss on at least one chromosomal arm. Samples of two patients (8%) showed LOH on almost all chromosomes. Fractional allelic loss, calculated for each sample as the total number of chromosomal arms lost/total number of arms with information, showed a median value of 0.04 and a mean of 0.123 (range, 0 to 0.95). This fractional allelic loss is lower than those reported for many solid tumors. This analysis shows the extreme power of LOH analysis using microsatellite markers in childhood ALL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585604

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

Authors:  H Ishii; R Baffa; S I Numata; Y Murakumo; S Rattan; H Inoue; M Mori; V Fidanza; H Alder; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

3.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.

Authors:  Hyewon Park; Jungwon Hyun; Sung Sup Park; Myoung Hee Park; Eun Young Song
Journal:  Korean J Lab Med       Date:  2011-10-03

5.  Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes.

Authors:  Y Hatta; S Takeuchi; J Yokota; H P Koeffler
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Computer aided analysis of additional chromosome aberrations in Philadelphia chromosome positive acute lymphoblastic leukaemia using a simplified computer readable cytogenetic notation.

Authors:  Jutta Bradtke; Harald Balz; Christa Fonatsch; Barbara Heinze; Anna Jauch; Brigitte Mohr; Claudia Schoch; Harald Rieder
Journal:  BMC Bioinformatics       Date:  2003-01-28       Impact factor: 3.169

7.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

8.  Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population.

Authors:  Elżbieta Złowocka-Perłowska; Aleksandra Tołoczko-Grabarek; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2022-01-04       Impact factor: 2.857

9.  Is PML a Tumor Suppressor?

Authors:  Massimiliano Mazza; Pier Giuseppe Pelicci
Journal:  Front Oncol       Date:  2013-07-09       Impact factor: 6.244

10.  p16 (INK4a) has clinicopathological and prognostic impact on oropharynx and larynx squamous cell carcinoma.

Authors:  S D Silva; S Nonogaki; F A Soares; L P Kowalski
Journal:  Braz J Med Biol Res       Date:  2012-09-06       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.